On Thursday (18th September), the White House declared war again, but on antibiotic-resistant bacteria – a far less controversial decision. The initial multi-pronged strategy includes the following executive actions: Formation of a new inter-agency task force to develop a 5-year national action plan to implement the: National Strategy for Combating Antibiotic-Resistant Bacteria. Launching a USD20 […]

http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(12)70300-6/fulltext This open access article was published more than a year and a half ago in Lancet Infectious Diseases – one of the top journals for clinical infectious diseases research. 2,061 patients aged 18 years and older from 12 European countries were recruited when they presented to primary care (GP) practices for acute lower respiratory […]

An incredible work from the Oxford University Clinical Research Unit. The visual displays of the distribution of human infectious diseases and their determinants are outstanding. Best of all, it is open access. The Atlas team intend for this to be a crowdsourcing effort, although at present it is not clear how that is to be […]

The newly renovated Tuberculosis Control Unit building and outpatient clinics. Airy and pleasant.      

In the Sunday Times today, Editor at Large Han Fook Kwang wrote on the issue of overcharging by doctors and the healthcare industry, with one of the points being how the promotion of medical tourism in Singapore had perhaps also helped to promote such a culture (“Doctors v Doctors” – behind a paywall so I won’t […]

Antimicrobial resistance is one of the greatest challenges of human health in general, and the field of infectious diseases in particular. It is – at its most basic level – an “arms race” between humans developing effective (and safe) antimicrobial compounds for the treatment of infections, and microbes developing or acquiring resistance determinants to these […]